NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo: sympathetic co-transmission during leukocyte mobilization

J Neuroimmunol. 2002 Nov;132(1-2):25-33. doi: 10.1016/s0165-5728(02)00278-3.

Abstract

Sympathetic nervous system (SNS) activation mobilizes blood leukocytes. Under these circumstances, both epinephrine (EPI) and neuropeptide Y (NPY) are released. Therefore, we investigated a possible interaction between these transmitters during leukocyte mobilization, using intravenous catheterization of male adult Lewis rats. Intravenous application of NPY followed by EPI, dose-dependently facilitated, intensified and inhibited EPI-induced leukocytosis with subset-specificity for NK-cells, monocytes, and B-lymphocytes. Pharmacological assessment of NPY receptors involved revealed a Y-1R-mediated inhibition and a Y-5R-mediated facilitation. RT-PCR on peripheral blood mononuclear cells (PBMC) detected Y-1R mRNA only, suggesting direct Y-1R-mediated effects on leukocytes and indirect effects via the Y-5R. Thus, via a specific Y-1R/Y-5R interplay, NPY acts as a neuroimmune co-transmitter in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Movement / drug effects
  • Epinephrine / pharmacology*
  • Leukocytes / drug effects*
  • Leukocytosis / chemically induced*
  • Male
  • Neuropeptide Y / pharmacology*
  • RNA, Messenger / analysis
  • Rats
  • Rats, Inbred Lew
  • Receptors, Neuropeptide Y / genetics
  • Receptors, Neuropeptide Y / physiology*
  • Synaptic Transmission

Substances

  • Neuropeptide Y
  • RNA, Messenger
  • Receptors, Neuropeptide Y
  • neuropeptide Y-Y1 receptor
  • neuropeptide Y5 receptor
  • Epinephrine